Want to see OPRX full AI Analyst Report?
OPRX Stock Chart & Stats
$6.24
$0.11(1.76%)
At close: 4:00 PM EDT
$6.24
$0.11(1.76%)
Day’s Range― - ―
52-Week Range$4.54 - $22.25
Previous CloseN/A
Volume41.31K
Average Volume (3M)393.42K
Market Cap
$145.23M
Enterprise Value$102.84
Total Cash (Recent Filing)$24.10M
Total Debt (Recent Filing)$19.48M
Price to Earnings (P/E)31.6
Beta2.05
Next Earnings
Nov 10, 2026EPS Estimate
0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.24
Shares Outstanding18,835,950
10 Day Avg. Volume233,316
30 Day Avg. Volume393,417
Financial Highlights & Ratios
PEG Ratio-0.35
Price to Book (P/B)1.77
Price to Sales (P/S)2.08
P/FCF Ratio12.19
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$13.67Price Target Upside119.02% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.94
Revenue Forecast (FY)$97.41M
Bulls Say, Bears Say
Bulls Say
Strong Cash Generation And Lower LeverageImproving operating cash flow and rapid debt reduction strengthen liquidity and financial flexibility. Lower leverage can reduce refinancing risk and allow more internally generated cash to support product investment or further balance-sheet improvement.
Platform Innovation Expands Recurring Growth OpportunitiesNew EHR, audience-intelligence, and copay capabilities deepen OptimizeRx’s role in healthcare workflows while broadening monetization. Growth in AI-enabled subscription software also supports a more recurring revenue mix over time.
Profitability And Margin Structure ImprovedThe shift from prior losses to positive operating profitability, together with strong gross margins and expense discipline, indicates a more resilient operating model. Sustained mix improvement could help protect cash generation even if growth remains uneven.
Bears Say
Revenue Contraction And Customer ConcentrationA sharp decline tied to a few large pharmaceutical accounts exposes the business to material customer-specific volatility. Concentration can make revenue recovery less predictable and may pressure margins if lost volume is not replaced.
Weak Retention And Uncertain Revenue VisibilityRetention below 100% indicates existing-account revenue is contracting, increasing the need for new bookings or expansion to restore growth. Timing uncertainty further complicates planning and raises execution risk around the reaffirmed outlook.
Recent Earnings Remain Below Prior-year LevelsDespite the broader profitability turnaround, the latest quarter produced a GAAP loss and lower adjusted earnings year over year. If revenue softness persists, weaker operating leverage could limit margin expansion and cash conversion.
OptimizeRx News
OPRX FAQ
What was Optimizerx Corporation’s price range in the past 12 months?
Optimizerx Corporation lowest stock price was $4.54 and its highest was $22.25 in the past 12 months.
What is Optimizerx Corporation’s market cap?
Optimizerx Corporation’s market cap is $145.23M.
When is Optimizerx Corporation’s upcoming earnings report date?
Optimizerx Corporation’s upcoming earnings report date is Nov 10, 2026 which is in 79 days.
How were Optimizerx Corporation’s earnings last quarter?
Optimizerx Corporation released its earnings results on Aug 12, 2026. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.111 by $0.049.
Is Optimizerx Corporation overvalued?
According to Wall Street analysts Optimizerx Corporation’s price is currently Undervalued.
Does Optimizerx Corporation pay dividends?
Optimizerx Corporation does not currently pay dividends.
What is Optimizerx Corporation’s EPS estimate?
Optimizerx Corporation’s EPS estimate is 0.18.
How many shares outstanding does Optimizerx Corporation have?
Optimizerx Corporation has 18,835,950 shares outstanding.
What happened to Optimizerx Corporation’s price movement after its last earnings report?
Optimizerx Corporation reported an EPS of $0.16 in its last earnings report, beating expectations of $0.111. Following the earnings report the stock price went up 24.716%.
Which hedge fund is a major shareholder of Optimizerx Corporation?
Currently, no hedge funds are holding shares in OPRX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
OptimizeRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.67 (119.02% Upside)
$13.67 (119.02% Upside)
Blogger Sentiment
Bullish
OPRX Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 201.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.1%
Last 30 Days ▼ 2.0%
Last 30 Days ▼ 2.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.54%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-2.92%
Trailing 12-Months
Company Description
Optimizerx Corporation
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
OPRX Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: the company delivered an operational beat in Q2, demonstrated margin expansion, launched meaningful product innovations and improved cash/debt metrics, but faced a sizable 30% YoY revenue decline, a dip in net revenue retention to 90%, GAAP loss, and concentration/timing risks tied to a few large customers. Management reiterated full-year guidance and highlighted multiple levers (product launches, mid-market growth, margin optimization, debt reduction) to drive recovery, yet near-term visibility remains uncertain.View all OPRX earnings summariesOPRX Stock 12 Month Forecast
Average Price Target
$13.67
▲(119.02% Upside)
Technical Analysis
Ownership Overview
7.54% Insiders
15.27% Mutual Funds
28.45% Other Institutional Investors
43.44% Public Companies and
Individual Investors